Skip to main content
OpenTrials

Clinical trial condition

First or Second Relapse

Explore clinical trials studying First or Second Relapse. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

First or Second Relapse trial results

Completed

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse

NCT01217203

Conditions
First or Second Relapse, Patients With Multiple Myeloma Experiencing a
Locations
  • Dana Farber Boston, Massachusetts, United States
  • NYU Clinical Cancer Center New York, United States
  • Mount Sinai Medical Center New York, United States
  • The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions